Norroy Bioscience Co., LTD clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.
- Notable: 177Lu-NYM032 Injection · Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Recruitment opened
- Notable: Distribution,Radiation Safety and Sensitivity/Specificity of PET/CT Imaging With 68Ga-NYM096 · IRM Recruitment opened
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 3 | 3 |
Disease areas by active trials
Prostate Cancer (4) · Kidney Cancer (1)
Get alerts when Norroy Bioscience Co., LTD's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.